Potential Coronavirus Treatments Enter Large Clinical Trials | The Institute for Creation Research
Potential Coronavirus Treatments Enter Large Clinical Trials
Some good news in potential treatment options for COVID-19 was reported in the American journal Science.1 Four new treatment options were being tried in a large-scale study across multiple countries. Currently, about 15% of COVID-19 patients need to be treated in a hospital or similar setting and some facilities and staff are being swamped. Science reported,

The World Health Organization (WHO) announced a large global trial, called SOLIDARITY, to find out whether any can treat infections with the new coronavirus for the dangerous respiratory disease. It’s an unprecedented effort—an all-out, coordinated push to collect robust scientific data rapidly during a pandemic. The study, which could include many thousands of patients in dozens of countries, has been designed to be as simple as possible so that even hospitals overwhelmed by an onslaught of COVID-19 patients can participate.1

What is remarkable is that so much political red tape was surmounted so quickly. In fact, this trial has a similar European counterpart, called Discovery, that will include patients from France, Spain, the United Kingdom, Germany, and the Benelux countries. These trials aim to discover as quickly as possible what does and does not work. They are using existing drugs with a familiar track record for safety and efficacy against other viral diseases bearing some similarities to COVID-19.

The drugs being tried include the following: the anti-malarial drugs chloroquine and hydroxychloroquine, the antiviral drug remdesivir, a ritonavir/lopinavir combination, and ritonavir/lopinavir in conjunction with interferon-beta (a molecule involved in regulating immune responses in the body).

No timeline was reported as to when results would be forthcoming. But, it is possible that some initial findings might even give indications of efficacy. These will likely be shared with the medical community and the public at large.

Getting so many politicians, bureaucrats, and clinicians to align for a common purpose so quickly could elicit the exclamation, “That’s a miracle!” Perhaps these clinical trials are an answer to prayer, since “The king’s heart is in the hand of the Lord, like the rivers of water; He turns it wherever He wishes.”2

References
1. Kupferschmidt, K. and J. Cohen. 2020. WHO launches global megatrial of the four most promising coronavirus treatments. Science. Posted on sciencemag.org March 22, 2020, accessed March 25, 2020.
2. Proverbs 21:1.

*Randy Guliuzza is ICR’s National Representative. He earned his Doctor of Medicine from the University of Minnesota, his Master of Public Health from Harvard University, and served in the U.S. Air Force as 28th Bomb Wing Flight Surgeon and Chief of Aerospace Medicine. Dr. Guliuzza is also a registered Professional Engineer.
The Latest
NEWS
Great American Outdoors Act, Signed into Law by President
In a bipartisan legislative achievement to promote better stewardship of American public lands, U.S. Senators and Representatives finalized their bill...

NEWS
Grandmothers, Eat Fish to Protect Your Brains!
This month the American Academy of Neurology published a medical science study showing that senior women can fight air pollution hazards, including brain...

NEWS
Embarrassment Continues over Evolutionary Blunder about “Junk...
Recent research from the Okinawa Institute of Science and Technology Graduate University (OIST) continues to highlight how evolutionary theory influenced...

NEWS
God’s Plan Is Best: Salmon Need Saltwater Acclimation
Once again, results are better when aquaculture imitates the natural life cycle of Atlantic salmon.1,2 In other words, the closer fish farmers...

NEWS
Inside August 2020 Acts & Facts
Have you heard about ICR’s new President and Chief Operating Officer, Dr. Randy Guliuzza? What can we learn from an old prayer? Is creation evidence...

NEWS
After 30 Years, Red Kites Soar in British Skies
Good news is always welcome. So, it’s good to learn of another conservation comeback. This time it’s the red kite happily soaring in Great...

CREATION PODCAST
Meet Dr. G
Hear the history and heart of ICR’s newly appointed President and Chief Operating Officer, Dr. Randy Guliuzza. He has served as ICR’s National...

ACTS & FACTS
'Doing Business' in Good Times and Bad
No doubt many of you, like me, have been earnestly looking for the return of the Lord Jesus Christ. He called all believers to be godly “salt”...

APOLOGETICS
Sentinels Are Needed in Perilous Times
Watch out! Dangers lurk everywhere—these are surely perilous times.1 One of the apologetics-exhorting themes in Jude’s epistle...

ACTS & FACTS
Why Don't Raindrops Bomb Butterfly Wings?
Okay, I admit most folks have probably not thought to ask this creation question. But a bigger question gets answered when we examine the fantastic...